Literature DB >> 7359191

Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients.

P M Black.   

Abstract

Of 62 patients given shunts for normal-pressure hydrocephalus of idiopathic type, 46.8% showed some improvement and 27.4% enjoyed virtually complete recovery. The best clinical predictor of good response was the complete triad of memory difficulty, gait disorder, and urine incontinence; 61.2% of patients with this combination of symptoms improved. Gait disturbance alone was also accompanied by improvement in two of three patients. An "obstructive" cisternographic radioisotope pattern was not significantly different from a "normal" pattern in predicting a response to shunting. Computerized tomography (CT) showing large ventricles and little atrophy predicted improvement in 11 out of 13 patients. There were five deaths within 3 months of shunting. The complication rate was 35.4%; subdural collections, shunt malfunction, and postoperative seizures constituted the most frequent complications. These data suggest that continued investigation for better predictions of shunt response is important, but that in the meantime the clinical pattern and cranial CT pattern are the most satisfactory guides to improvement after shunting.

Entities:  

Mesh:

Year:  1980        PMID: 7359191     DOI: 10.3171/jns.1980.52.3.0371

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  41 in total

Review 1.  Idiopathic normal-pressure hydrocephalus in adults: result of shunting correlated with clinical findings in 18 patients and review of the literature.

Authors:  R Caruso; L Cervoni; A M Vitale; M Salvati
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

2.  Does the shunt opening pressure influence the effect of shunt surgery in normal pressure hydrocephalus?

Authors:  A Larsson; C Jensen; M Bilting; S Ekholm; H Stephensen; C Wikkelsö
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  CSF proteomic analysis in patients with normal pressure hydrocephalus selected for the shunt: CSF biomarkers of response to surgical treatment.

Authors:  Antonio Scollato; Alessandro Terreni; Anna Caldini; Benedetta Salvadori; Pasquale Gallina; Simona Francese; Guido Mastrobuoni; Giuseppe Pieraccini; Gloriano Moneti; Luca Bini; Gianni Messeri; Nicola Di Lorenzo
Journal:  Neurol Sci       Date:  2009-11-21       Impact factor: 3.307

Review 4.  Brain imaging techniques in the diagnosis of dementia.

Authors:  A L Powell; D F Benson
Journal:  Neuropsychol Rev       Date:  1990-03       Impact factor: 7.444

5.  Normal pressure hydrocephalus.

Authors:  M Anderson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04

6.  Normal pressure hydrocephalus presenting as Parkinson's syndrome.

Authors:  A Miodrag; T K Das; R J Shepherd
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

7.  Effectiveness of shunting in patients with normal pressure hydrocephalus predicted by temporary, controlled-resistance, continuous lumbar drainage: a pilot study.

Authors:  I H Chen; C I Huang; H C Liu; K K Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

8.  Decreases in ventricular volume correlate with decreases in ventricular pressure in idiopathic normal pressure hydrocephalus patients who experienced clinical improvement after implantation with adjustable valve shunts.

Authors:  Kathleen A McConnell; Kelly H Zou; Alexandra V Chabrerie; Nancy Olsen Bailey; Peter McL Black
Journal:  Neurosurgery       Date:  2004-09       Impact factor: 4.654

9.  Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study.

Authors:  Masaaki Hashimoto; Masatsune Ishikawa; Etsuro Mori; Nobumasa Kuwana
Journal:  Cerebrospinal Fluid Res       Date:  2010-10-31

10.  Features of gait most responsive to tap test in normal pressure hydrocephalus.

Authors:  Lisa D Ravdin; Heather L Katzen; Anna E Jackson; Diamanto Tsakanikas; Stephanie Assuras; Norman R Relkin
Journal:  Clin Neurol Neurosurg       Date:  2008-03-21       Impact factor: 1.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.